New Study Shows Cloning from Dried Cells Now Possible
... MT. LAUREL, N.J., Sept. 8 /PRNewswire/ -- Core dynamics Inc. today announced that cloning with ... for clinical use." About Core Dynamics: Core dynamics is a privately held biotechnology company that ... are located in Mt. Laurel, New Jersey. Core dynamics hopes to develop additional applications through ...Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
... USA: Robert D. Stanislaro Evan Smith Financial dynamics Financial dynamics T: 212-850-5657 T: 212-850-5606 E: ...Progen Announces PI-88 Phase 2 Lung Cancer Results
... Media Relations USA: Robert D. Stanislaro Financial dynamics T: 212-850-5657 E: robert.stanislaro@fd.com Investor Relations USA: Evan Smith Financial dynamics T: 212-850-5606 E: evan.smith@fd.com ...Hand Washing with 4% CHG Antiseptic Kills Flu Viruses
... and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment. ...USAID Provides $5M in Emergency Support as Swine Flu Spreads
... Control and Prevention, to work with authorities in Mexico. The team will further investigate and characterize the virulence and transmission dynamics of the disease. USAID is responding to the international outbreak in coordination with the Centers for Disease Control and Prevention (CDC). To ...First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008
... impact of climate change on major flooding in Europe (Institute for Meteorology in Berlin) Project dedicated to the study of the impact and dynamics of marine aliens in the context of climate change (Queen's University Belfast) Project dedicated to assessing civil conflict risks ...Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
... on condoms or abstinence as methods for protecting themselves from HIV. Even a partially effective microbicide could have a profound impact on the dynamics of HIV transmission. According to mathematical modeling conducted by the London School of Hygiene and Tropical Medicine, 2.5 million HIV infections ...Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline
... Enquiries Biotica Technology Ltd Tel: +44-1799-532920 Dr Edward E. Hodgkin, CEO enquiries@biotica.com Financial dynamics Tel: +44(0)20-7831-3113 Ben Atwell Ben.Atwell@fd.com ...Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand
... Isogen can ramp follow-on funding to expand its presence in the biopharma industry. "Isogen will help our customers address major industry dynamics that are reshaping the face and complexity of sterile clinical trials materials supply," said Edwards. "Regulators in the U.S. and Europe ...Elsevier is Expanding eClinical Solutions in Europe
... throughout their workday." Capturing 'e' Opportunities Elsevier is uniquely positioned to replicate its success in the U.S. abroad. Market dynamics are different, as European E-Health markets and Elsevier's positions within them are at an earlier stage of development than in the U.S. However, key ...Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting
... Dr. Poland's presentation, entitled "Using in Vitro and Literature Data to Predict Effects of New Anti-Retrovirals", will describe how PK/PD-viral dynamics models developed using preclinical data and literature data on existing HIV treatments can inform dose-response predictions for new anti-retroviral ...Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid
... U.S. Investor and Media Contacts: Harry Rosen Brian Ritchie Phosphagenics Limited Financial dynamics President and CEO Tel +1 212 850 5683 Tel +61 3 9605 5900 Mary McSwiggan Phosphagenics Limited Investor Relations Manager ...West Pharmaceutical Services, Inc. Appoints New Director
... Japan, Asia and Australia. Contacts: Investors and Financial Media: West Pharmaceutical Services, Inc. Financial dynamics Michael A. Anderson Evan Smith/Theresa Kelleher Vice President and Treasurer (212) 850-5600 (610) 594-3345 ...Molnlycke Drives 'Home' the Fight Against Staph and Other MRSA Infections
... and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment. (1) Bell, Edward A. "Antibiotic Choices for ...New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
... First comprehensive study of market dynamics offers insights into what will be needed to get ... results from the first comprehensive study of the dynamics of the global TB drug market that offers a ... The study, Pathway to Patients: Charting the dynamics of the Global TB Drug Market, reveals the ...CeNeS Pharmaceuticals plc: Update on Successful Phase III results announced on Lead Product M6G
... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
... of our three lead compounds, yet clinical and preclinical data for these product candidates demonstrate that subtle differences in microtubule dynamics can lead to different approaches to the treatment of cancer. Panzem(R), MKC-1 and ENMD-1198 are all orally-active yet distinct tubulin ...CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006
... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
... as peripheral neuropathy, an impairment of peripheral nervous system function. Neuropathies are thought to result when these drugs interfere with the dynamics of microtubule filaments that are responsible for the long-distance transport of important cellular components within nerve cells. Mitotic kinesins ...EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models
... tubulin protein, either in the monomer form or polymerized in microtubules, and prevent cancer cell proliferation by interfering with the microtubule dynamics required for cell division. This interference blocks the cell cycle sequence, leading to cell death (apoptosis). About EntreMed EntreMed, Inc. is ...Telomerase Presentations at the AACR 2007 Annual Meeting
... to form aggressive tumors. Information in Dr. DePinho's talk and other presentations throughout the AACR meeting on the regulation of telomere dynamics and telomerase activity elucidates the potential for telomerase-inhibiting molecules in the treatment of cancer. Cancer Stem Cells Cancer stem ...Independent publication supports the profile of CeNeS phase II compound, CNS 5161
... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...FDA approves IND on Lead Product M6G
... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
... peripheral neuropathy, an impairment of peripheral nervous system function. Neuropathies are thought to result when these drugs interfere with the dynamics of microtubule filaments that are responsible for the long-distance transport of important cellular components within nerve cells. Mitotic kinesins ...Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
... please contact: CeNeS Pharmaceuticals plc Neil Clark, CEO Tel: +44 (0)1223 266 466 JM Finn Geoff Nash Tel: +44(0) 207 628 9688 Financial dynamics Ben Brewerton/Emma Thompson Tel: + 44 (0) 207 831 3113 About CeNeS Pharmaceuticals CeNeS is a biopharmaceutical company specialising in the ...